Comparison of efficacy of ivermectin and diethylcarbamazine against naturally infected microfilaria in dogs.
Clicks: 246
ID: 70463
2019
Filarial parasites like and can infect dogs. Adults of genus resides in the lymphatic system and microfilariae, in blood. There are increasing reports of detection of microfilariae in dogs. A study was undertaken to compare the efficacy of repeated oral dosing of ivermectin (IVT) and diethylcarbamazine (DEC), individually and in combination against naturally infected microfilariae in dogs. The species of the microfilariae was confirmed by acid phosphatase staining and polymerase chain reaction. The three treatment groups were 200 mcg/kg body weight IVT daily for 14 days (I), 6.6 mg/kg body weight DEC daily for 14 days (II) and IVT and DEC together in the same dose for a period of 5 days (III). Microfilarial status of the peripheral blood was assessed on the 0th, 7th, 14th and 21st day. Haematological parameters were measured on day zero and on the 21st day. Though, all the three treatment groups showed a reduction in the microfilarial concentration through the study period, complete absence of detectable microfilaremia was not noticed in any of the three groups by 21st day. Among the haematological parameters, statistically significant difference was observed in the post-treatment means of haemoglobin levels of group III when compared with group II. Since group III regime (IVT + DEC) was shorter and just as effective as the longer ones, it is considered superior to the other two.
Reference Key |
sadarama2019comparisonjournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Sadarama, Poojary Vineeta;Chirayath, Deepa;Pillai, Usha Narayana;Lakshmanan, Bindu; |
Journal | Journal of parasitic diseases : official organ of the Indian Society for Parasitology |
Year | 2019 |
DOI | 10.1007/s12639-019-01126-2 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.